Apheresis blood processing with heparin improves stem cell collection outcomes for sickle cell gene therapy

Authors: David Justus, Carly Howard, Ellen Proeung, Aimee Sarnie, Jen Fortin, Erica Esrick, Matthew Heeney, Daniel Bauer, Sarah Nikiforow, Jose Cancelas, Leslie Lehmann, David Williams, John Manis

Published: November 3, 2025

Click Here to Read More
Previous
Previous

Household material hardship as a barrier to accessing sickle cell disease curative therapy

Next
Next

The feasibility of collecting social determinants of health in the national multi-center GRASP sickle cell gene therapy trial